Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of...
Gespeichert in:
| Veröffentlicht in: | BMC psychiatry 2013-12, Vol.13 (1), p.338-338, Article 338 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 338 |
|---|---|
| container_issue | 1 |
| container_start_page | 338 |
| container_title | BMC psychiatry |
| container_volume | 13 |
| creator | Sado, Mitsuhiro Takechi, Sayuri Inagaki, Ataru Fujisawa, Daisuke Koreki, Akihiro Mimura, Masaru Yoshimura, Kimio |
| description | The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.
A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics.
The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US $1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion.
The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation. |
| doi_str_mv | 10.1186/1471-244X-13-338 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3878364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534619590</galeid><sourcerecordid>A534619590</sourcerecordid><originalsourceid>FETCH-LOGICAL-b697t-5f6ec0809e2e7d2f596a4b595dc62533032235267cbb9874f09c357a1954176f3</originalsourceid><addsrcrecordid>eNqNkstrFTEUxoNY7EP3rmTAjZupeT9cCOXSVqXgRsFdyGSSNmUmGZO5xf73zXDr5V6pULLI4ZzvfBx-5wDwFsFThCT_iKhALab0V4tIS4h8AY62qZc78SE4LuUWQiQkQ6_AIaaEQUnREbhcpTI3yTcm_gluvm_6UFLuXS5NiM03M5m4BBhC-akxzZTdnRlctK7tTHF9Y6YpJ2NvXoMDb4bi3jz-J-DnxfmP1Zf26vvl19XZVdtxJeaWee4slFA57ESPPVPc0I4p1luOGSGQYEwY5sJ2nZKCeqgsYcIgxSgS3JMT8HnjO6270fXWxTmbQU85jCbf62SC3q_EcKOv050mUkjCaTVYbQy6kP5jsF-xadQLSL2A1Ijoyrm6fHgcI6ffa1dmPYZi3TCY6NK61AaFOZQSi-dIoah4Ka_S9_9Ib9M6x8pzmQBSijjZUV3XTegQfapz2sVUnzFCeWWlYFWdPqGqr3djsCk6H2p-rwFuGmxOpWTnt0wQ1Mu1PUXh3e4ytg1_z4s8AHHqy-8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1470441636</pqid></control><display><type>article</type><title>Cost of anxiety disorders in Japan in 2008: a prevalence-based approach</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><creator>Sado, Mitsuhiro ; Takechi, Sayuri ; Inagaki, Ataru ; Fujisawa, Daisuke ; Koreki, Akihiro ; Mimura, Masaru ; Yoshimura, Kimio</creator><creatorcontrib>Sado, Mitsuhiro ; Takechi, Sayuri ; Inagaki, Ataru ; Fujisawa, Daisuke ; Koreki, Akihiro ; Mimura, Masaru ; Yoshimura, Kimio</creatorcontrib><description>The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.
A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics.
The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US $1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion.
The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.</description><identifier>ISSN: 1471-244X</identifier><identifier>EISSN: 1471-244X</identifier><identifier>DOI: 10.1186/1471-244X-13-338</identifier><identifier>PMID: 24350841</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult ; Aged ; Analysis ; Anxiety ; Anxiety disorders ; Anxiety Disorders - economics ; Anxiety Disorders - epidemiology ; Cost of Illness ; Economic aspects ; Efficiency ; Female ; Health Care Costs ; Health care expenditures ; Health care policy ; Health insurance ; Humans ; Illnesses ; Japan ; Japan - epidemiology ; Male ; Medical care, Cost of ; Medical technology ; Mental Health Services - economics ; Middle Aged ; Mortality ; Patients ; Prevalence ; Psychiatry ; Public health ; Social aspects ; Social service ; Somatoform disorders</subject><ispartof>BMC psychiatry, 2013-12, Vol.13 (1), p.338-338, Article 338</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>2013 Sado et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Sado et al.; licensee BioMed Central Ltd. 2013 Sado et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b697t-5f6ec0809e2e7d2f596a4b595dc62533032235267cbb9874f09c357a1954176f3</citedby><cites>FETCH-LOGICAL-b697t-5f6ec0809e2e7d2f596a4b595dc62533032235267cbb9874f09c357a1954176f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878364/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878364/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24350841$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sado, Mitsuhiro</creatorcontrib><creatorcontrib>Takechi, Sayuri</creatorcontrib><creatorcontrib>Inagaki, Ataru</creatorcontrib><creatorcontrib>Fujisawa, Daisuke</creatorcontrib><creatorcontrib>Koreki, Akihiro</creatorcontrib><creatorcontrib>Mimura, Masaru</creatorcontrib><creatorcontrib>Yoshimura, Kimio</creatorcontrib><title>Cost of anxiety disorders in Japan in 2008: a prevalence-based approach</title><title>BMC psychiatry</title><addtitle>BMC Psychiatry</addtitle><description>The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.
A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics.
The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US $1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion.
The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.</description><subject>Adult</subject><subject>Aged</subject><subject>Analysis</subject><subject>Anxiety</subject><subject>Anxiety disorders</subject><subject>Anxiety Disorders - economics</subject><subject>Anxiety Disorders - epidemiology</subject><subject>Cost of Illness</subject><subject>Economic aspects</subject><subject>Efficiency</subject><subject>Female</subject><subject>Health Care Costs</subject><subject>Health care expenditures</subject><subject>Health care policy</subject><subject>Health insurance</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Japan</subject><subject>Japan - epidemiology</subject><subject>Male</subject><subject>Medical care, Cost of</subject><subject>Medical technology</subject><subject>Mental Health Services - economics</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patients</subject><subject>Prevalence</subject><subject>Psychiatry</subject><subject>Public health</subject><subject>Social aspects</subject><subject>Social service</subject><subject>Somatoform disorders</subject><issn>1471-244X</issn><issn>1471-244X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkstrFTEUxoNY7EP3rmTAjZupeT9cCOXSVqXgRsFdyGSSNmUmGZO5xf73zXDr5V6pULLI4ZzvfBx-5wDwFsFThCT_iKhALab0V4tIS4h8AY62qZc78SE4LuUWQiQkQ6_AIaaEQUnREbhcpTI3yTcm_gluvm_6UFLuXS5NiM03M5m4BBhC-akxzZTdnRlctK7tTHF9Y6YpJ2NvXoMDb4bi3jz-J-DnxfmP1Zf26vvl19XZVdtxJeaWee4slFA57ESPPVPc0I4p1luOGSGQYEwY5sJ2nZKCeqgsYcIgxSgS3JMT8HnjO6270fXWxTmbQU85jCbf62SC3q_EcKOv050mUkjCaTVYbQy6kP5jsF-xadQLSL2A1Ijoyrm6fHgcI6ffa1dmPYZi3TCY6NK61AaFOZQSi-dIoah4Ka_S9_9Ib9M6x8pzmQBSijjZUV3XTegQfapz2sVUnzFCeWWlYFWdPqGqr3djsCk6H2p-rwFuGmxOpWTnt0wQ1Mu1PUXh3e4ytg1_z4s8AHHqy-8</recordid><startdate>20131218</startdate><enddate>20131218</enddate><creator>Sado, Mitsuhiro</creator><creator>Takechi, Sayuri</creator><creator>Inagaki, Ataru</creator><creator>Fujisawa, Daisuke</creator><creator>Koreki, Akihiro</creator><creator>Mimura, Masaru</creator><creator>Yoshimura, Kimio</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131218</creationdate><title>Cost of anxiety disorders in Japan in 2008: a prevalence-based approach</title><author>Sado, Mitsuhiro ; Takechi, Sayuri ; Inagaki, Ataru ; Fujisawa, Daisuke ; Koreki, Akihiro ; Mimura, Masaru ; Yoshimura, Kimio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b697t-5f6ec0809e2e7d2f596a4b595dc62533032235267cbb9874f09c357a1954176f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analysis</topic><topic>Anxiety</topic><topic>Anxiety disorders</topic><topic>Anxiety Disorders - economics</topic><topic>Anxiety Disorders - epidemiology</topic><topic>Cost of Illness</topic><topic>Economic aspects</topic><topic>Efficiency</topic><topic>Female</topic><topic>Health Care Costs</topic><topic>Health care expenditures</topic><topic>Health care policy</topic><topic>Health insurance</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Japan</topic><topic>Japan - epidemiology</topic><topic>Male</topic><topic>Medical care, Cost of</topic><topic>Medical technology</topic><topic>Mental Health Services - economics</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patients</topic><topic>Prevalence</topic><topic>Psychiatry</topic><topic>Public health</topic><topic>Social aspects</topic><topic>Social service</topic><topic>Somatoform disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sado, Mitsuhiro</creatorcontrib><creatorcontrib>Takechi, Sayuri</creatorcontrib><creatorcontrib>Inagaki, Ataru</creatorcontrib><creatorcontrib>Fujisawa, Daisuke</creatorcontrib><creatorcontrib>Koreki, Akihiro</creatorcontrib><creatorcontrib>Mimura, Masaru</creatorcontrib><creatorcontrib>Yoshimura, Kimio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sado, Mitsuhiro</au><au>Takechi, Sayuri</au><au>Inagaki, Ataru</au><au>Fujisawa, Daisuke</au><au>Koreki, Akihiro</au><au>Mimura, Masaru</au><au>Yoshimura, Kimio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost of anxiety disorders in Japan in 2008: a prevalence-based approach</atitle><jtitle>BMC psychiatry</jtitle><addtitle>BMC Psychiatry</addtitle><date>2013-12-18</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>338</spage><epage>338</epage><pages>338-338</pages><artnum>338</artnum><issn>1471-244X</issn><eissn>1471-244X</eissn><abstract>The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.
A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics.
The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US $1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion.
The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24350841</pmid><doi>10.1186/1471-244X-13-338</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1471-244X |
| ispartof | BMC psychiatry, 2013-12, Vol.13 (1), p.338-338, Article 338 |
| issn | 1471-244X 1471-244X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3878364 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central |
| subjects | Adult Aged Analysis Anxiety Anxiety disorders Anxiety Disorders - economics Anxiety Disorders - epidemiology Cost of Illness Economic aspects Efficiency Female Health Care Costs Health care expenditures Health care policy Health insurance Humans Illnesses Japan Japan - epidemiology Male Medical care, Cost of Medical technology Mental Health Services - economics Middle Aged Mortality Patients Prevalence Psychiatry Public health Social aspects Social service Somatoform disorders |
| title | Cost of anxiety disorders in Japan in 2008: a prevalence-based approach |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A23%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost%20of%20anxiety%20disorders%20in%20Japan%20in%202008:%20a%20prevalence-based%20approach&rft.jtitle=BMC%20psychiatry&rft.au=Sado,%20Mitsuhiro&rft.date=2013-12-18&rft.volume=13&rft.issue=1&rft.spage=338&rft.epage=338&rft.pages=338-338&rft.artnum=338&rft.issn=1471-244X&rft.eissn=1471-244X&rft_id=info:doi/10.1186/1471-244X-13-338&rft_dat=%3Cgale_pubme%3EA534619590%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1470441636&rft_id=info:pmid/24350841&rft_galeid=A534619590&rfr_iscdi=true |